Eitan Raveh, PhD, is Vice President of Clinical Partnerships at NeuraLight. He is a global clinical and regulatory affairs professional with more than 20 years of experience spanning medical centers, healthcare companies, and the medical device industry. Eitan began his career in clinical neurology before earning his PhD from the Faculty of Medicine at Tel Aviv University, where he specialized in the application of advanced technologies in medicine. He has since held leadership roles across multiple medical and healthcare organizations, combining deep clinical expertise with a strong business perspective to drive the adoption of innovative medical technologies. He joined NeuraLight in 2022 to lead clinical partnerships and help advance the company’s biomarker platform in CNS drug development.
We urgently need biomarkers that are sensitive, objective, and practical. Eye-movement measures are ready to fill this gap, not as distant innovations, but as tools available today.